Novel Pipeline of AI and Simulation Tools Could Make Process of Screening Drug Candidates for COVID-19 50,000 Times Faster
|
By HospiMedica International staff writers Posted on 15 Feb 2021 |

Image: Novel Pipeline of AI and Simulation Tools Could Make Process of Screening Drug Candidates for COVID-19 50,000 Times Faster (Photo courtesy of Argonne National Laboratory)
A novel pipeline of AI and simulation tools could make the process of screening drug candidates for COVID-19 50,000 times faster.
To find a drug that can stop the SARS-CoV-2 virus, scientists want to screen billions of molecules for the right combination of properties. The process is usually risky and slow, often taking several years. An international team of scientists from 10 organizations, including the US Department of Energy’s (DOE) Argonne National Laboratory (Lemont, IL, USA), have found a way to make the process 50,000 times faster using artificial intelligence (AI). The team has developed a pipeline of AI and simulation techniques, named IMPECCABLE, short for Integrated Modeling PipelinE for COVID Cure by Assessing Better Leads to hasten the discovery of promising drug candidates for COVID-19.
IMPECCABLE integrates multiple techniques for data processing, physics-based modeling and simulation, and machine learning, a form of AI that uses patterns in data to generate predictive models. At the start of the pipeline, computational techniques are used to calculate the basic properties of billions of molecules. This data is used in the next stage of the pipeline to create machine learning models that can predict how likely it is that a given molecule will bind with a known viral protein. Those found to be most promising are then simulated on high-performance computing systems.
Very large experimental data sets are also being gathered from thousands of protein crystals using X-rays at the Advanced Photon Source (APS), a DOE Office of Science User Facility on Argonne’s campus. The technique they’re using to get this data is known as X-ray crystallography. With it, researchers can capture detailed images of viral proteins and their chemical states to improve the accuracy of their machine learning models. The ultimate goals of the pipeline are to understand the function of viral proteins; identify molecules with a high potential to bind with these proteins and, as a result, block SARS-CoV-2 proliferation; and deliver this insight to drug designers and developers for further research and development.
“With the AI we’ve implemented, we’ve been able to screen four billion potential drug candidates in a matter of a day, while existing computational tools might only realistically screen one to 10 million,” said Thomas Brettin, strategic program manager at Argonne.
“Unlike the traditional approach, where you rely on the scientist to think really hard and, based on what they know, come up with ideas for a molecule, with our pipeline you can screen huge numbers of molecules automatically, dramatically increasing your chance of finding a likely candidate,” said Ian Foster, director of Argonne’s Data Science and Learning division.
Related Links:
Argonne National Laboratory
To find a drug that can stop the SARS-CoV-2 virus, scientists want to screen billions of molecules for the right combination of properties. The process is usually risky and slow, often taking several years. An international team of scientists from 10 organizations, including the US Department of Energy’s (DOE) Argonne National Laboratory (Lemont, IL, USA), have found a way to make the process 50,000 times faster using artificial intelligence (AI). The team has developed a pipeline of AI and simulation techniques, named IMPECCABLE, short for Integrated Modeling PipelinE for COVID Cure by Assessing Better Leads to hasten the discovery of promising drug candidates for COVID-19.
IMPECCABLE integrates multiple techniques for data processing, physics-based modeling and simulation, and machine learning, a form of AI that uses patterns in data to generate predictive models. At the start of the pipeline, computational techniques are used to calculate the basic properties of billions of molecules. This data is used in the next stage of the pipeline to create machine learning models that can predict how likely it is that a given molecule will bind with a known viral protein. Those found to be most promising are then simulated on high-performance computing systems.
Very large experimental data sets are also being gathered from thousands of protein crystals using X-rays at the Advanced Photon Source (APS), a DOE Office of Science User Facility on Argonne’s campus. The technique they’re using to get this data is known as X-ray crystallography. With it, researchers can capture detailed images of viral proteins and their chemical states to improve the accuracy of their machine learning models. The ultimate goals of the pipeline are to understand the function of viral proteins; identify molecules with a high potential to bind with these proteins and, as a result, block SARS-CoV-2 proliferation; and deliver this insight to drug designers and developers for further research and development.
“With the AI we’ve implemented, we’ve been able to screen four billion potential drug candidates in a matter of a day, while existing computational tools might only realistically screen one to 10 million,” said Thomas Brettin, strategic program manager at Argonne.
“Unlike the traditional approach, where you rely on the scientist to think really hard and, based on what they know, come up with ideas for a molecule, with our pipeline you can screen huge numbers of molecules automatically, dramatically increasing your chance of finding a likely candidate,” said Ian Foster, director of Argonne’s Data Science and Learning division.
Related Links:
Argonne National Laboratory
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Artificial Intelligence
view channel
AI Analysis of Smartwatch ECGs May Help Detect Weakened Heart Function
Left ventricular systolic dysfunction (LVSD) occurs when the heart’s main pumping chamber does not contract effectively. The condition can remain asymptomatic for some time but may progress to symptomatic... Read more
AI Tool Speeds Echocardiogram Reporting With Comparable Accuracy
Echocardiography is the most widely used form of cardiac imaging, playing a key role in diagnosing heart disease and guiding treatment decisions. However, reviewing ultrasound images and documenting cardiac... Read moreCritical Care
view channel
AI Models Improve Mortality Risk Prediction After PCI for STEMI
ST-elevation myocardial infarction (STEMI) is a heart attack caused by complete blockage of one or more coronary arteries. More than 2 million people worldwide develop STEMI each year. Percutaneous coronary... Read more
Updated Head Injury Guidelines Support Risk-Based CT and Observation Decisions
Head injuries are a common reason for emergency department visits, with most cases classified as mild. However, clinicians must identify patients at risk of intracranial bleeding or other serious injuries... Read moreSurgical Techniques
view channel
FDA Authorizes Robotic System for En Bloc Bladder Resection
Bladder cancer frequently recurs, making accurate staging essential for treatment planning. Conventional transurethral resection can fragment tumors, complicating margin assessment and detrusor muscle... Read more
Fluorescence Imaging Reveals Nerves Under Normal Operating-Room Lighting
Preventing unintended nerve injury remains a major concern during surgery, particularly in complex anatomical regions where nerves can be difficult to distinguish from surrounding tissue.... Read more
Programmable Microwave Ablation System Gains CE Mark for Minimally Invasive Tissue Ablation
Hospitals continue to seek minimally invasive approaches that simplify procedural planning and provide controlled energy delivery for tissue ablation. Thermal ablation systems are used across multiple... Read more
Minimally Invasive Balloon Procedure May Redirect Blood Flow During Cardiac Arrest
Out-of-hospital cardiac arrest has a low survival rate, and patients who do not respond to prolonged advanced resuscitation have few remaining treatment options. During cardiopulmonary resuscitation, blood... Read morePatient Care
view channelVirtual Reality Program May Reduce Anxiety Before Pediatric Surgery
Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more
Video-Based Support Helps Older Adults Clarify Kidney Disease Treatment Preferences
Advanced chronic kidney disease (CKD) involves progressive loss of kidney function that can lead to kidney failure and difficult treatment decisions. For older adults, these decisions may include choosing... Read moreMedical Imaging
view channel
Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis
Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more
MRI Test Identifies Candidates for Lower-Dose Radiotherapy in HPV Throat Cancer
Human papillomavirus (HPV)-positive oropharyngeal cancer is a throat cancer linked to HPV infection. Its incidence is rising, and many patients receive high-dose radiotherapy that can cause long-term swallowing... Read moreHealth IT
view channel
Clinical Decision Support Tool Automates CKD Risk Assessment in Primary Care
Chronic kidney disease (CKD) requires timely diagnosis, risk assessment, and coordinated treatment in primary care. Delayed recognition can affect decisions about testing, blood pressure control, cardiovascular... Read more
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read morePoint of Care
view channel
Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier
Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more
New Breath Condensate Testing Approach Enhances Reliability for COPD Monitoring
Chronic obstructive pulmonary disease (COPD) is a progressive lung condition that can increasingly impair breathing over time. Diagnosis and monitoring may be burdensome because patients often require... Read more
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read moreBusiness
view channel
Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings
Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more








